BEBT-109, a pan-mutant-selective EGFR inhibitor with potent antitumor activity in EGFR-mutant non-small cell lung cancer
Autor: | Fan, Fushun, Zhou, Minhua, Ye, Xiaolan, Mo, Zhenxian, Ma, Yaru, Luo, Liying, Liang, Xiaotong, Liu, Haiqi, Weng, Yunwo, Lin, Mingsheng, Liu, Xinjian, Cai, Xiong, Qian, Changgeng |
---|---|
Zdroj: | In Translational Oncology February 2021 14(2) |
Databáze: | ScienceDirect |
Externí odkaz: |